Hashimoto Thyroiditis: Autoimmune Destruction and Progressive Thyroid Failure

Core Idea

Hashimoto thyroiditis is CD8+ T cell-mediated and antibody-mediated autoimmune destruction of thyroid follicles, causing progressive thyroid atrophy and fibrosis. Loss of thyroid hormone production leads to overt hypothyroidism with TSH elevation and eventual myxedema if untreated.

Explainer

From your study of autoimmune disease mechanisms, you know that autoimmunity arises when central or peripheral tolerance fails — the immune system generates self-reactive lymphocytes that escape deletion or suppression and attack host tissue. In Hashimoto thyroiditis, the target antigens are proteins unique to thyroid follicular cells: thyroid peroxidase (TPO), the enzyme that oxidizes iodide to iodine during thyroid hormone synthesis, and thyroglobulin (Tg), the large scaffold protein inside follicles on which T3 and T4 are assembled. When the immune system generates antibodies and cytotoxic T cells against these proteins, it is dismantling the molecular machinery of hormone production.

The immune attack is coordinated and progressive. CD8+ cytotoxic T cells infiltrate the thyroid gland and directly kill follicular cells through perforin-granzyme pathways. Anti-TPO antibodies (found in >90% of Hashimoto patients) fix complement and recruit NK cells, amplifying follicular destruction through antibody-dependent cellular cytotoxicity. Anti-Tg antibodies appear in roughly 80% of patients. Histologically, the gland shows a characteristic dense lymphocytic infiltrate with germinal center formation — essentially a lymph node growing inside the thyroid — and progressive follicular atrophy replaced by fibrotic tissue.

The clinical progression follows the structural destruction. Early in the disease, as follicles rupture, preformed thyroid hormone spills into circulation, producing a transient Hashitoxicosis phase: brief hyperthyroid symptoms (palpitations, heat intolerance, anxiety) that can be mistaken for Graves disease. This passes as the stored hormone is exhausted and the gland loses capacity. As follicular mass decreases, T3 and T4 fall; the pituitary, freed from negative feedback, increases TSH secretion. Elevated TSH is the first detectable biochemical signal, appearing before T4 actually falls below normal — this subclinical hypothyroid phase can persist for years. Eventually, with sufficient follicular destruction, overt hypothyroidism develops: fatigue, cold intolerance, weight gain, bradycardia, and constipation reflecting slowed metabolism in every organ system. Untreated, profound hypothyroidism progresses to myxedema — a syndrome of accumulation of glycosaminoglycans in connective tissue, causing the characteristic non-pitting edema of skin, periorbital tissue, and tongue.

The feedback loop you studied in thyroid physiology is the key to understanding monitoring: TSH is exquisitely sensitive and is the earliest and most reliable marker of thyroid failure. A rising TSH in an otherwise well patient with anti-TPO antibodies identifies Hashimoto's even before symptoms appear, allowing early intervention with levothyroxine replacement before the physiological burden of chronic hypothyroidism accumulates.